Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: A European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study

Blood

Volumn 93, Issue 9, 1999, Pages 2831-2838

  Guardiola, Philippe ^a   Anderson, Jeanne E ^b   Bandini, Giuseppe ^b   Cervantes, Francisco ^b   Runde, Volker ^b   Arcese, William ^b   Bacigalupo, Andrea ^b   Przepiorka, Donna ^b   O'Donnell, Margaret R ^b   Polchi, Paola ^b   Buzyn, Agnès ^b   Sutton, Laurent ^b   Cazals Hatem, Dominique ^b   Sale, George ^b   De Witte, Theo ^b   Deeg, H Joachim ^b   Gluckman, Eliane ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHRONIC DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELOID METAPLASIA; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STEM CELL TRANSPLANTATION; TREATMENT FAILURE;

ADULT; ERYTHROCYTE TRANSFUSION; EUROPE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MULTIVARIATE ANALYSIS; MYELOID METAPLASIA; PROBABILITY; SPLENECTOMY; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES;

EID: 0033135848     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dameshek W: Some speculations on the myeloproliferative syndromes. Blood 6:372, 1951
2. Silverstein MN: Agnogenic Myeloid Metaplasia. Acton, MA, Publishing Sciences, 1975
3. Rozman C, Giralt M, Feliu E, Rubio D, Cortes MT: Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 67:2658, 1991
4. Cervantes F, Pereira A, Esteve J, Rafel M, Cobo F, Rozman C, Montserrat E: Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis. Br J Haematol 97:635, 1997
5. Kvasnicka HM: Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer 80:708, 1997
6. Hasselbalch H: Primary myelofibrosis: A clinical study of 80 patients. Am J Hematol 34:291, 1990
7. Varki A, Lottenberg R, Griffith R, Reinhard E: The syndrome of primary myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine 62:353, 1983
8. Visani G, Finelli C, Castelli U, Petti MC, Ricci P, Vianelli N, Gianni L, Zuffa E, Aloe Spiriti MA, Latagliata R, Pileri S, Magrini U, Gugliotta L, Morra E, Bernasconi C, Mandelli F: Myelofibrosis with myeloid metaplasia: Clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol 75:4, 1990
9. Ward HP, Block MH: The natural history of primary myelofibrosis (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 50:357, 1971
10. Barosi G, Berzuini C, Liberato LN, Costa A, Polino G, Ascari E: A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol 70:397, 1988
11. Dupriez B, Morel P, Demory JL, Lai JL, Simon M, Plantier I, Bauters F: Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system. Blood 88:1013, 1996
12. Besa EC, Nowell PC, Geller NL, Gardner FH: Analysis of the androgen response of 23 patients with primary myelofibrosis. Cancer 49:308, 1982
13. Löfvenberg E, Wahlin A, Roos G, Öst A: Reversal of myelofibrosis by hydroxyurea. Eur J Haematol 44:33, 1990
14. Silver RT: Interferons in the treatment of myeloproliferative diseases. Semin Hematol 27:6, 1990 (suppl 4)
15. Sacchi S: The role of α-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): A concise update. Leuk Lymphoma 19:13, 1995
16. Reilly JT: Idiopathic myelofibrosis: Pathogenesis, natural history and management. Blood Rev 11:233, 1997
17. Tefferi A, Silverstein MN, Noel P: Agnogenic myeloid metaplasia. Semin Oncol 22:327, 1995
18. Silverstein MN, ReMine WH: Splenectomy in myeloid metaplasia. Blood 53:515, 1979
19. Ben-Bassat I, Gilon D, Penchas S: The choice between splenectomy and medical treatment in patients with advanced primary myelofibrosis. Am J Hematol 33:128, 1990
20. Barosi G, Ambrosetti A, Buratti A, Finelli C, Liberato NL, Quaglini S, Ricetti MM, Visani G, Tura S, Ascari E: Splenectomy for patients with myelofibrosis with myeloid metaplasia: Pretreatment variables and outcome prediction. Leukemia 7:200, 1993
21. Morel P, Demory JL, Dupriez B: Relevance of prognostic features in myeloid metaplasia to selection of patients for bone marrow transplantation. Blood 89:2219, 1997
22. Guardiola Ph, Espérou H, Cazals-Hatem D, Ifrah N, Jouet JP, Buzyn A, Sutton L, Gratecos N, Tilly H, Lioure B, Gluckman E: Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. Br J Haematol 98:1004, 1997
23. Anderson JE, Sale G, Appelbaum FR, Chauncey TR, Storb R: Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythemia vera or essential thrombocytosis. Br J Haematol 98:1010, 1997
24. Laszlo J: Myeloproliferative disorders (MPD): Myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 12:409, 1975
25. Sultan C, Scoazec JY, Imbert M: Histopathologie de la moelle osseuse. Paris, France, Masson, 1991
26. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipient of marrow from HLA-matched sibling donors. Transplantation 18:295, 1974
27. Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
28. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
29. Cox DR: Regression models and life tables. J R Stat Soc 34:187, 1972
30. Singhal S, Powles R, Treleaven J, Pollard C, Lumley H, Mehta J: Allogeneic bone marrow transplantation for primary myelofibrosis. Bone Marrow Transplant 16:743, 1995
31. Schmitz N, Suttorp M, Schlegelberger B, Weber-Matthiesen K, Tiemann M, Sonnen R: The role of the spleen after bone marrow transplantation for primary myelofibrosis. Br J Haematol 81:616, 1992
32. O'Donnell MR, Nademanee AP, Snyder DS, Schmidt GM, Parker PM, Bierman PJ, Fahey JL, Stein AS, Krance RA, Stock AD, Forman SJ, Blume KG: Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J Clin Oncol 5:1822, 1987
33. Creemers GJ, Löwenberg B, Hagenbeek A: Allogeneic bone marrow transplantation for primary myelofibrosis. Br J Haematol 82:772, 1992
34. Dokal I, Jones L, Deenmamode M, Lewis SM, Goldman JM: Allogeneic bone marrow transplantation for primary myelofibrosis. Br J Haematol 71:158, 1989
35. Ifrah N, Gardembas-Pain M, Hunault M, Saint-André JP, Foussard C, Boasson M: Allogeneic bone marrow transplantation for primary myelofibrosis. Br J Haematol 73:575, 1989
36. Przepiorka D, Giralt S, Khouri I, Champlin R, Bueso-Ramos C: Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases. Am J Hematol 57:24, 1998
37. Iwata N, Inoue N, Tamura A, Miyazaki E, Fujimori Y, Okamoto T, Takemoto Y, Kosaki M, Kanamaru A, Kakishita E: Primary myelofibrosis successfully treated with allogeneic bone marrow transplantation. Jpn J Clin Hematol 33:1703, 1992
38. Rossbach HC, Grana NH, Chamizo W, Barrios NJ, Barbosa JL: Successful allogeneic bone marrow transplantation for agnogenic myeloid metaplasia in a 3-year-old boy. J Pediatr Hematol Oncol 18:213, 1996
39. Reilly JT, Nash JR: Vitronectin (serum spreading factor): Its localisation in normal and fibrotic tissue. J Clin Pathol 41:1269, 1988
40. Sturmhofel K, Brando C, Martinon F, Shevach EM, Coligan JE: Antigen-independent, integrin-mediated T cell activation. J Immunol 154:2104, 1995
41. Moulder K, Roberts K, Shevach EM, Coligan JE: The mouse vitronectin receptor is a T cell activation antigen. J Exp Med 173:343, 1991
42. Cervantes F, Barosi G, Demory JL, Reilly JT, Guarnone R, Dupriez B, Pereira A, Montserrat E: Myelofibrosis with myeloid metaplasia in young individuals: Disease characteristics, prognostic factors and identification of risk-groups. Br J Haematol 102:684, 1998
43. Clift RA, Buckner CD, Thomas ED, Doney K, Fefer A, Neiman PE, Singer J, Sanders J, Stewart P, Sullivan KM, Deeg J, Storb R: Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet 2:621, 1982